uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
A select combination of neurotrophins enhances neuroprotection and functional recovery following spinal cord injury
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences, Anaesthesiology and Intensive Care.
2007 (English)In: Neuroprotective agents: Eighth international neuroprotection society meeting / [ed] Slikker W; Andrew RJ; Trembly B, 2007, Vol. 1122, 95-111 p.Conference paper (Refereed)
Abstract [en]

Previously, we have shown that topical application of brain-derived neurotrophic factor (BDNF) or insulin-like growth factor 1 (IGF-1) given within 5 to 30 min after a focal trauma to the rat spinal cord attenuates spinal cord injury (SCI)-induced breakdown of the blood-spinal cord barrier (BSCB), edema formation, motor dysfunction, and cell injury. This investigation was undertaken to find out whether a combination of select neurotrophins (BDNF, glial cell line-derived neurotrophic factor [GDNF], neurotrophin 3 [NT-3], or nerve growth factor [NGF]) will further enhance the neuroprotective efficacy of growth factors in SCI. The neurotrophins (0.1-1 microg/10 microL in phosphate-buffered saline) were applied 30, 60, or 90 min after injury topically over the traumatized spinal cord either alone or in combination. The SCI was performed by making a unilateral incision into the right dorsal horn of the T10-T11 segment under Equithesin anesthesia. The rats were allowed to survive 5 h after trauma. Topical application of BDNF, GDNF, or NGF 30 min after SCI in high concentration (0.5 microg and 1 microg) significantly improved the motor functions and reduced the BSCB breakdown, edema formation, and cell injury seen at 5 h. These beneficial effects of neurotropins were absent when administered separately either 60 or 90 min after SCI. However, a combination of BDNF and GDNF (but not with NT-3 or NGF) given either 60 or 90 min after SCI significantly reduced the motor dysfunction and spinal cord pathology at 5 h. These novel observations suggest that a select group of neurotrophins in combination have potential therapeutic value for the treatment of SCI in clinical situations.

Place, publisher, year, edition, pages
2007. Vol. 1122, 95-111 p.
, Annals of the New York academy of sciences, ISSN 0077-8923 ; 1122
Keyword [en]
Animals, Behavior, Animal, Blood-Brain Barrier/drug effects/physiopathology, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Therapy, Combination, Hindlimb/drug effects/physiopathology, Male, Motor Activity/drug effects, Nerve Growth Factors/*therapeutic use, Neuroprotective Agents/*therapeutic use, Rats, Rats, Sprague-Dawley, Recovery of Function/*drug effects/physiology, Spinal Cord Injuries/*drug therapy/pathology/physiopathology, Time Factors
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-17159DOI: 10.1196/annals.1403.007ISI: 000252267100007PubMedID: 18077567OAI: oai:DiVA.org:uu-17159DiVA: diva2:44930
8th International Conference on Neuroprotective Agents Mackinac Isl, MI, SEP 18-20, 2006
Available from: 2008-06-17 Created: 2008-06-17 Last updated: 2011-03-24Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=18077567&dopt=Citation

Search in DiVA

By author/editor
Sharma, Hari Shanker
By organisation
Anaesthesiology and Intensive Care
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 135 hits
ReferencesLink to record
Permanent link

Direct link